Assessment of myocardial scarring by contrast enhanced magnetic resonance imaging in a patient 11 years after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy

被引:2
|
作者
Butz, T. [1 ,2 ]
Horstkotte, D. [2 ]
Koerfer, J. [3 ]
Langer, C. [2 ]
Seggewiss, H. [4 ]
Faber, L. [2 ]
机构
[1] Ruhr Univ Bochum, Dept Cardiol & Angiol, Marienhosp, D-44627 Herne, Germany
[2] Ruhr Univ Bochum, Dept Cardiol, Heart & Diabet Ctr N Rhine Westphalia, Bad Oeynhausen, Germany
[3] Ruhr Univ Bochum, Inst Radiol Nucl Med & Mol Imaging, Heart & Diabet Ctr N Rhine Westphalia, Bad Oeynhausen, Germany
[4] Leopoldina Hosp Schweinfurt, Schweinfurt, Germany
关键词
Hypertrophic obstructive cardiomyopathy; Septal ablation; PTSMA; Magnetic resonance imaging; MRI; Myocardial scar; VENTRICULAR OUTFLOW TRACT;
D O I
10.1016/j.ijcard.2008.12.096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report on a 60 year-old male who was one of the first patients who underwent percutaneous transluminal septal myocardial ablation (PTSMA) in our institution in 1996. Contrast enhanced cardiac magnetic resonance imaging (MRI) 11 years after the PTSMA demonstrated extensive scarring, in septal and inferior segments of the left ventricle, and an excellent functional result. It has been previously demonstrated that contrast-enhanced MRI allows detailed evaluation of size and location of septal myocardial infarction induced by PTSMA, and that infarction size detected by MRI correlates well with clinical indexes of infarct size. Our case report underlines the importance of ongoing specialized care and reassessment of patients after PTSMA including continuous clinical risk assessment. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:E3 / E5
页数:3
相关论文
共 50 条
  • [31] Clinical characteristics and cardiac magnetic resonance for the patients received repeat percutaneous transluminal septal myocardial ablation in refractory hypertrophic obstructive cardiomyopathy
    Kitamura, M.
    Amano, Y.
    Shibuya, J.
    Matsuda, J.
    Nakamura, S.
    Takano, H.
    Asai, K.
    Takayama, M.
    Shimizu, W.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1084 - 1084
  • [32] Morrow septal myectomy and percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy, a single centre comparison
    Scholzel, B. E.
    Swaans, M. J.
    Idzerda, H. H. D.
    Bergmeijer, T.
    Kelder, J. C.
    Yilmaz, A.
    Schepens, M. A. A. M.
    Ten Berg, J. M.
    EUROPEAN HEART JOURNAL, 2008, 29 : 56 - 56
  • [33] Comparison of percutaneous transluminal septal myocardial ablation and septal myectomy in hypertrophic obstuctive cardiomyopathy
    Qin, JX
    Shiota, T
    Lever, HM
    Rubin, DN
    Bauer, F
    Tsujino, H
    Drinko, JK
    Martin, M
    Thomas, JD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 191A - 192A
  • [34] Identification of the target vessel (TV) in percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy (HOCM) by myocardial contrast echocardiography (MCE)
    Faber, L
    Seggewiss, H
    Fassbender, D
    Strick, S
    Bogunovic, N
    Gleichmann, U
    CIRCULATION, 1997, 96 (08) : 3577 - 3577
  • [35] Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy
    Veselka, J
    Honek, T
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2003, 88 (01) : 27 - 32
  • [36] MR imaging evaluation of regional, remote, and global effects of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy
    Amano, Yasuo
    Takayama, Morimasa
    Kumita, Shinichiro
    Kumazaki, Tatsuo
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2007, 31 (04) : 600 - 604
  • [37] Anesthetic management of a patient with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation: Early postinterventional period and anesthetic considerations
    Kita, T
    Nakata, K
    Mammoto, T
    Kishi, Y
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2001, 15 (03) : 362 - 363
  • [38] Percutaneous transluminal septal myocardial ablation markedly reduces energy loss in hypertrophic obstructive cardiomyopathy: a four-dimensional flow magnetic resonance imaging study
    Dai, Z.
    Iguchi, N.
    Takamisawa, I
    Takayama, M.
    Nanasato, M.
    Kanisawa, M.
    Mizuno, N.
    Isobe, M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2081 - 2081
  • [39] Intracardiac echocardiography guidance during percutaneous transluminal septal myocardial ablation in patients with obstructive hypertrophic cardiomyopathy
    Pedone, C
    Vijayakumar, M
    Biagini, E
    Serruys, PW
    ten Cate, FJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 301A - 302A